Boston Scientific shares fall as key segment's performance spooks investors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Boston Scientific (BSX) PT Lowered to $105 at Piper Sandler, 'Buy The Dip'
February 4, 2026 9:46 AM EST(Updated - February 4, 2026 9:52 AM EST)
Piper Sandler analyst Matt O\'Brien lowered the price target on Boston Scientific (NYSE: BSX) to $105.00 (from $120.00) while maintaining a Overweight rating.
"Q4 Beat But Key Drivers Deceleration to Weight on Stock; Buy The Dip"... More